266 related articles for article (PubMed ID: 26319172)
1. Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.
Du X; Parent JM
Curr Neurol Neurosci Rep; 2015 Oct; 15(10):71. PubMed ID: 26319172
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming patient-derived cells to study the epilepsies.
Parent JM; Anderson SA
Nat Neurosci; 2015 Mar; 18(3):360-6. PubMed ID: 25710838
[TBL] [Abstract][Full Text] [Related]
3. Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy.
Sterlini B; Fruscione F; Baldassari S; Benfenati F; Zara F; Corradi A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940887
[TBL] [Abstract][Full Text] [Related]
4. Modeling genetic epilepsies in a dish.
Niu W; Parent JM
Dev Dyn; 2020 Jan; 249(1):56-75. PubMed ID: 31241228
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells.
Tidball AM; Parent JM
Stem Cells; 2016 Jan; 34(1):27-33. PubMed ID: 26373465
[TBL] [Abstract][Full Text] [Related]
6. 'Channeling' therapeutic discovery for epileptic encephalopathy through iPSC technologies.
Simkin D; Ambrosi C; Marshall KA; Williams LA; Eisenberg J; Gharib M; Dempsey GT; George AL; McManus OB; Kiskinis E
Trends Pharmacol Sci; 2022 May; 43(5):392-405. PubMed ID: 35427475
[TBL] [Abstract][Full Text] [Related]
7. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
[TBL] [Abstract][Full Text] [Related]
8. Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases.
Li L; Chao J; Shi Y
Cell Tissue Res; 2018 Jan; 371(1):143-151. PubMed ID: 29079884
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
Tanaka A; Yuasa S; Node K; Fukuda K
Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
[TBL] [Abstract][Full Text] [Related]
10. Gene correction in patient-specific iPSCs for therapy development and disease modeling.
Jang YY; Ye Z
Hum Genet; 2016 Sep; 135(9):1041-58. PubMed ID: 27256364
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
12. Genome editing in pluripotent stem cells: research and therapeutic applications.
Deleidi M; Yu C
Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
[TBL] [Abstract][Full Text] [Related]
13. Application of induced pluripotent stem cells in epilepsy.
Hirose S; Tanaka Y; Shibata M; Kimura Y; Ishikawa M; Higurashi N; Yamamoto T; Ichise E; Chiyonobu T; Ishii A
Mol Cell Neurosci; 2020 Oct; 108():103535. PubMed ID: 32758699
[TBL] [Abstract][Full Text] [Related]
14. Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived Systems.
Trevisan M; Sinigaglia A; Desole G; Berto A; Pacenti M; Palù G; Barzon L
Viruses; 2015 Jul; 7(7):3835-56. PubMed ID: 26184286
[TBL] [Abstract][Full Text] [Related]
15. Stem cells: A path towards improved epilepsy therapies.
Lybrand ZR; Goswami S; Hsieh J
Neuropharmacology; 2020 May; 168():107781. PubMed ID: 31539537
[TBL] [Abstract][Full Text] [Related]
16. The use of induced pluripotent stem cells for studying and treating optic neuropathies.
Khan S; Hung SS; Wong RC
Curr Opin Organ Transplant; 2016 Oct; 21(5):484-9. PubMed ID: 27517502
[TBL] [Abstract][Full Text] [Related]
17. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
18. Modeling human neurological disorders with induced pluripotent stem cells.
Imaizumi Y; Okano H
J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
[TBL] [Abstract][Full Text] [Related]
19. Induced pluripotent stem cells for modeling of pediatric neurological disorders.
Jang J; Quan Z; Yum YJ; Song HS; Paek S; Kang HC
Biotechnol J; 2014 Jul; 9(7):871-81. PubMed ID: 24838856
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells and their implication for regenerative medicine.
Csobonyeiova M; Polak S; Koller J; Danisovic L
Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
